首页> 外文期刊>海南医科大学学报(英文版) >Clinical observation of hysteroscopic surgery combined with ectopic pregnancy ⅱ decoction and methotrexate in the treatment of cesarean scar pregnancy
【24h】

Clinical observation of hysteroscopic surgery combined with ectopic pregnancy ⅱ decoction and methotrexate in the treatment of cesarean scar pregnancy

机译:宫腔镜手术联合异位妊娠ⅱ汤加甲氨蝶呤治疗剖宫产疤痕妊娠的临床观察

获取原文
获取原文并翻译 | 示例
           

摘要

Objective:To explore the effectiveness and safety about the treatment of Caesarean Scar Pregnancy combined hysteroscopic surgery with extopic pregnancy Ⅱ decoction and methotrexate(MTX).Methods: A total of 80 cases of CSP patients admitted by our hospital from January 2014 to March 2017 were selected as the subjects. According to the treatment way, the patients were divided into experimental group (n=40) and control group (n=40). The control group was given MTX 50 mg/m2, IM once; and the experimental group was given extopic pregnancy Ⅱ decoction on the basis of the treatment given to the control group; the 8th day hysteroscopic surgery. Routine treatment was given after surgery. Experimental group continued to take extopic pregnancy Ⅱ decoction until monitoring the serum beta-hcg level drops below normal. The general information and curative effect, HCG levels before and after 4, 7 and 11d of treatment; mass diameter before and after 11 d of treatment, menstruation recovery time and the incidence of adverse reactions in 2 groups were observed.Results:After hysteroscopic surgery pretreatment with extopic pregnancy Ⅱ decoction and MTX, HCG levels after 4, 7 and 11d were significantly lower than before, it gradually reduced by time prolonged, and research group was lower than control group, the differences were statistically significant. After treatment with different drugs, the size of pregnancy package in the observation group was significantly smaller than that in the control group. Compared with the control group, the he package block size, beta HCG time and vaginal bleeding time were significantly reduced.Conclusion: It has significant clinical effect of hysteroscopic surgery combined with ectopic pregnancy Ⅱ and MTX in the treatment of CSP. It has worthy of clinical promotion to control the amount of blood, avoid intrauterine adhesion caused by uterine artery embolization and infection et al and reduce burden of the physical and economic of patients.
机译:目的:探讨沉重妊娠Ⅱ次汤和甲氨蝶呤(MTX)治疗剖腹瘢痕妊娠联合宫腔镜手术的有效性和安全性。方法:2014年1月至2017年3月,我们医院共录得80例CSP患者选择为主题。根据治疗方式,将患者分为实验组(n = 40)和对照组(n = 40)。对照组给予MTX 50 mg / m2,即时;实验组在给予对照组的治疗的基础上令人置信怀孕Ⅱ汤;第8天宫腔镜手术。手术后给予常规处理。实验组继续略微妊娠Ⅱ汤,直至监测血清β-HCG水平低于正常情况。一般信息和疗效,4,7和11D治疗前后的HCG水平;观察到11 d前后的质量直径,月经恢复时间和2组不良反应的发生率。结果:在宫腔镜手术预处理Ⅱ次煎剂和MTX后,4,7和11d后的HCG水平显着降低比以前,它逐步减少时间延长,研究组低于对照组,差异有统计学意义。在用不同的药物处理后,观察组妊娠包的大小明显小于对照组。与对照组相比,HE包块尺寸,βHCG时间和阴道出血时间显着降低。结论:它具有宫腔镜手术与异位妊娠Ⅱ和MTX治疗CSP的显着临床疗效。它有价值对控制血液量的临床促进,避免子宫动脉栓塞和感染等引起的宫内粘附,并减少患者的身体和经济负担。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号